Patents by Inventor David H. Harris

David H. Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020038079
    Abstract: A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined.
    Type: Application
    Filed: June 13, 2001
    Publication date: March 28, 2002
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 6266546
    Abstract: A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined.
    Type: Grant
    Filed: May 28, 1998
    Date of Patent: July 24, 2001
    Assignee: In-Line Diagnostics Corporation
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 5803908
    Abstract: A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined.It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 8, 1998
    Assignee: In-Line Diagnostics Corporation
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 5499627
    Abstract: A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined.It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique.
    Type: Grant
    Filed: October 4, 1994
    Date of Patent: March 19, 1996
    Assignee: In-Line Diagnostics Corporation
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 5456253
    Abstract: A disposable cuvette through which to pass pulsatile flowing blood. The cuvette has a conduit with two opposed walls having a predetermined separation therebetween that varies with each pulse of the flowing blood. A sealed air pocket damps the variation of the predetermined separation. The conduit is comprised of materials which permit passage therethrough of wavelengths of selected electromagnetic radiation. The radiation is emitted from a photoemitter which, and after passing through the cuvette, is detected by a photodetector. The quantities of detected radiation are operated on by a computer which uses a spectrophotometry technique to derive therefrom a blood constituent concentration value. Preferably, both cuvette and spectrophotometry technique are used during hemodialysis to derive changes in the hematocrit value of the blood of a dialyzed patient, thereby to deduce therefrom changes in the blood volume of the patient during dialysis.
    Type: Grant
    Filed: September 27, 1994
    Date of Patent: October 10, 1995
    Assignee: In-Line Diagnostics Corporation
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 5372136
    Abstract: A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined.It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique.
    Type: Grant
    Filed: February 1, 1993
    Date of Patent: December 13, 1994
    Assignee: Noninvasive Medical Technology Corporation
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 5351686
    Abstract: A disposable cuvette through which to pass pulsatile flowing blood. The cuvette has a conduit with two opposed walls having a predetermined separation therebetween that varies with each pulse of the flowing blood. A sealed air pocket damps the variation of the predetermined separation. The conduit is comprised of materials which permit passage therethrough of wavelengths of selected electromagnetic radiation. The radiation is emitted from a photoemitter which, and after passing through the cuvette, is detected by a photodetector. The quantities of detected radiation are operated on by a computer which uses a spectrophotometry technique to derive therefrom a blood constituent concentration value. Preferably, both cuvette and spectrophotometry technique are used during hemodialysis to derive changes in the hematocrit value of the blood of a dialyzed patient, thereby to deduce therefrom changes in the blood volume of the patient during dialysis.
    Type: Grant
    Filed: May 24, 1993
    Date of Patent: October 4, 1994
    Assignee: In-Line Diagnostics Corporation
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 4906763
    Abstract: A preceramic substituted borazine polymer of the formula: ##STR1## wherein R is methyl, ethyl, propyl, or butyl, and x is a positive integer. Also disclosed are methods for making the polymer, methods for converting the polymer into coatings, shaped articles, articles including fibers and filaments formed from the polymer, blends of the foregoing polymer and preceramic triamino-N-tris (trialkylsilyl) borazines, and methods for thermally decomposing the foregoing polymers to form shaped articles of boron nitride.
    Type: Grant
    Filed: November 13, 1987
    Date of Patent: March 6, 1990
    Inventors: Kazimiera J. L. Paciorek, Reinhold H. Kratzer, David H. Harris, Wilfried Krone-Schmidt
  • Patent number: 4711248
    Abstract: A portable physiological pressure monitoring device adapted for being attached to a body part of a patient in which the compartment pressure is to be continuously monitored. The device includes an alarm for indicating when a predetermined maximum pressure limit is exceeded or when a predetermined minimum pressure is not maintained for a certain period of time. The pressure device also includes a hydrophobic filter which separates a catheter and the sensing components of the pressure device for providing sterile operation. A warning also sounds when a battery falls below a given voltage level. Finally, the pressure monitoring device also includes apparatus for measuring nerve conduction velocity and action potential to facilitate better diagnosis and monitoring of compartment syndrome.
    Type: Grant
    Filed: December 1, 1983
    Date of Patent: December 8, 1987
    Assignee: Biokinetics, Inc.
    Inventors: Robert R. Steuer, David H. Harris
  • Patent number: 4707556
    Abstract: Silyl containing cyclic borazines are prepared by reacting chloroborazine with disilazanes.
    Type: Grant
    Filed: February 13, 1987
    Date of Patent: November 17, 1987
    Assignee: Ultrasystems Defense and Space, Inc.
    Inventors: Kazimiera J. L. Paciorek, Reinhold H. Kratzer, David H. Harris, Wilfried Krone-Schmidt
  • Patent number: 4581468
    Abstract: B-triamino-N-tris(trialkylsilyl)borazines, their condensation products, and the transformation of these into preceramic polymers amenable to fiber drawing and ultimately boron nitride fiber formation.
    Type: Grant
    Filed: May 13, 1985
    Date of Patent: April 8, 1986
    Assignee: Ultrasystems, Inc.
    Inventors: Kazimiera J. L. Paciorek, Reinhold H. Kratzer, David H. Harris, Mark E. Smythe, Patrick F. Kimble
  • Patent number: 4559175
    Abstract: This invention concerns itself with a novel class of dihalodiphospha-s-triazines as exemplified by the compound 1,3-bis[phenylchloro-phospha]-5-perfluoro-n-heptyl-2,4,6-triazines as well as their thio and azido substituted derivatives.
    Type: Grant
    Filed: April 19, 1984
    Date of Patent: December 17, 1985
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Kazimiera J. L. Paciorek, Reinhold H. Kratzer, David H. Harris, Mark E. Smythe, James H. Nakahara
  • Patent number: 4557869
    Abstract: This invention concerns itself with a class of novel dihalo-substituted monophospha-s-triazines as exemplified by the compounds 1-dichlorophospha-3,5-bis(perfluoro-n-heptyl)-2,4,6-triazine and 1-dichlorophospha-3,5-bis[C.sub.3 F.sub.7 OCF(CF.sub.3)CF.sub.2 OCF(CF.sub.3)]-2,4,6-triazine, as well as their thio and azido derivatives.
    Type: Grant
    Filed: April 19, 1984
    Date of Patent: December 10, 1985
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Kazimiera J. L. Paciorek, Reinhold H. Kratzer, David H. Harris, Mark E. Smythe, James H. Nakahara
  • Patent number: 4504263
    Abstract: A flow monitor including an optical sensing chamber and an electronic controller which allows determination of exact drop volumes and flow rates. In one embodiment, the flow monitor forms part of a gravity fed volumetric controller in an IV system. In another embodiment, the flow monitor takes the form of a urinary output monitor in a urine collection system. Basically, the flow monitor comprises a microcontroller which responds to parametric information fed into the system through a keyboard and variable information detected by a novel drop diameter detector. The electronic controller, in response to the parametric and variable information being fed into it, is able to determine the precise volume of IV solution or urine passing through the respective systems. In the volumetric controller, the microcontroller causes a linear actuator to control the diameter of a flexible pinch tube found in the IV system. Under one mode of operation, the diameter of the pinch tube is regulated to control drop size.
    Type: Grant
    Filed: November 10, 1983
    Date of Patent: March 12, 1985
    Assignee: ValleyLab, Inc.
    Inventors: Robert R. Steuer, David H. Harris